utahmed.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

FORM 8-K

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934


Date of Report (date of earliest event reported): May 3, 2013

Commission File No. 001-12575

UTAH MEDICAL PRODUCTS, INC.
(Exact name of Registrant as specified in its charter)


UTAH
87-0342734
(State or other jurisdiction of  incorporation or organization)
 (I.R.S. Employer Identification No.)


7043 South 300 West
Midvale, Utah  84047
Address of principal executive offices


Registrant's telephone number:
(801) 566-1200

 
 
 

ITEM 5.07.   SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

On May 3, 2013 at the annual meeting, shareholders of the Company approved or indicated their preference on the following matters submitted to them for consideration:

Elected Barbara A. Payne as a director of the Company:
 
For
2,849,261
Withheld
141,750
    
             
Approved the 2013 Employees’ and Directors’ Incentive Plan:
 
For
2,304,518
Against
674,497
Abstentions
11,996
             
Ratified the selection of Jones Simkins LLC as the Company’s independent public accounting firm for the year ended December 31, 2013:
 
For
3,463,280
Against
13,504
Abstentions
7,653
             
Approved, on an advisory basis, the compensation paid to UTMD’s named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion:
 
For
2,846,990
Against
83,180
Abstentions
60,841
 
 
 
 

SIGNATURES


Pursuant to the requirements of the Securities Exchanges Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


 
UTAH MEDICAL PRODUCTS, INC.
 
REGISTRANT
   
   
Date:     5/07/2013
By:  /s/ Kevin L. Cornwell
 
Kevin L. Cornwell
 
CEO